“Peptide therapy” is an umbrella phrase, not one treatment. Peptides are short chains of amino acids, and different compounds can have entirely different targets, evidence, legal status, formulations, and risks. A claim about one peptide says little about another.
Quick take: ask three separate questions: Is there credible human evidence for this specific use? What is the product’s regulatory status? How will quality, safety, and follow-up be handled?
Start with the exact compound and goal
“Recovery,” “performance,” and “healthy aging” are broad marketing ideas. A useful clinical conversation names the symptom or goal, the exact ingredient, the proposed route, and the measurable outcome. It should also consider established alternatives with better evidence.
Use an evidence ladder
- Mechanism: a plausible biological idea, often from laboratory work.
- Animal data: useful for research questions, but not proof of human benefit.
- Early human studies: helpful, though often small or short.
- Controlled clinical trials: stronger evidence when well designed and relevant.
- Replicated outcomes and guidance: confidence grows when multiple groups find meaningful benefit with acceptable risk.
For example, a recent systematic review of BPC-157 literature found that much of the evidence came from laboratory and animal studies, with very limited human evidence. That gap should be stated plainly rather than filled with testimonials.
FDA approval and compounding are different questions
An FDA-approved drug has been reviewed for a particular product, indication, labeling, manufacturing process, and benefit-risk profile. A compounded drug is not FDA approved; the FDA does not review compounded products for safety, effectiveness, or quality before marketing. Compounding can address a specific patient need in appropriate circumstances, but it does not turn limited clinical evidence into established benefit.
Online red flags
- Guaranteed outcomes or dramatic before-and-after promises.
- “Research use only” products sold with instructions for human use.
- No licensed clinician screening or no way to ask follow-up questions.
- No clear pharmacy, ingredient, concentration, storage, or administration information.
- Claims that a compounded product is the same as an FDA-approved product.
- Pressure to stack several products before trying one measurable plan.
Questions worth asking
- What exact human studies support this use and route?
- What is unknown about long-term safety?
- Is this product FDA approved, prescribed off label, or compounded?
- Why this option instead of better-studied alternatives?
- How will benefit, side effects, and stopping rules be measured?
- What symptoms require urgent evaluation?
Frequently asked questions
Does “naturally occurring” mean safe?
No. A molecule related to a natural body process can still have dose-dependent effects, interactions, contamination risks, and unknowns.
Are all compounded peptides illegal?
No broad statement fits every compound or circumstance. Federal and state rules, substance eligibility, prescription requirements, and pharmacy practices all matter. Ask for the exact regulatory and sourcing details.
Sources and editorial note
- FDA: Consumer and health professional information about compounded drugs
- PubMed: Systematic review of BPC-157 in orthopaedic sports medicine
Educational information only; not medical advice or a claim that any peptide is safe or effective for you. Prescription treatment requires an independent clinician evaluation. Compounded drugs are not FDA approved.